However, unlike at the transcriptomic level, where meningiomas with CDKN2A homodel had the highest CDK4 expression, CDKN2A homodel meningiomas showed lower levels of CDK4 protein, although only 3 tumors in this group were profiled here. This evidence concerns the gene CDK4 and meningioma.